Phase 2 Rare Disease Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (male or female)
- You have been diagnosed with a specific type of brain or spinal tumor — such as glioblastoma that has stopped responding to treatment, a certain type of astrocytoma or oligodendroglioma, or other rare primary brain tumors — confirmed by a tissue sample analyzed according to current medical standards
- Your overall health and ability to carry out daily activities meets a certain minimum level, as measured by a standard medical scoring tool (confirm with trial site)
- Your doctor expects you to live for more than 12 weeks
- Your doctor has determined that you have limited other treatment options available, regardless of how many treatments you have already tried
- Surgery is medically recommended for you, and a tissue sample confirming a recurring brain tumor will be needed before any treatment in the trial begins
- Your blood, kidney, and liver function are at acceptable levels
- You are able to understand what the study involves, sign a consent form, and agree to follow the study's rules and attend required appointments
Who may not be able to join:
- You are unable to have an MRI scan of the brain or spine
- You are currently receiving other drug treatments aimed at treating your tumor
- You are planning to receive radiation therapy
- You are currently taking part in another experimental anti-tumor treatment study
- Your doctor feels you are unlikely to follow the study's procedures and requirements
- You are pregnant, or you intend to become pregnant during the study; women who could potentially become pregnant must have a negative pregnancy test before joining
- You are currently breastfeeding and are not willing to stop nursing before the first treatment and for the period specified in the study guidelines
- You are sexually active and able to have children, but are not willing to use an effective form of contraception throughout the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +41442555500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To demonstrate the overall feasibility of pharmacoscopy-guided treatment for patients with refractory primary brain tumors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.